Ordinarily it is no big deal when someone is walking along and has a slight stumble. Put that same person on a mountainside, though, and that stumble is suddenly quite a bit more serious. That might be one way to think about Danaher's (NYSE:DHR) second quarter earnings - there was not all that much to object to, but Danaher carries a hefty premium due in part to a reputation for excellent execution. That may just be something to keep in mind if investors find themselves reading about a "disappointing" quarter.
Solid Second Quarter Results
While Danaher did report a fairly gaudy growth rate of over 15% for the second quarter, organic growth was a more modest 7.5%. Organic growth was led by test/measurement and industrial tech, while the environmental unit saw a small organic revenue decline. Danaher's dental business looked like a bit of a laggard (but still up more than 6%) and life sciences was relatively solid.
To continue, please follow this link:
Danaher Delivers On High Expectations (DHR, BRK.A, SI, TMO, PAY, XRAY, GE)
No comments:
Post a Comment